CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 115 enrolled
Drug / intervention
PicoWay™ 532nm fractional handpiece +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03774849
NCT03774849N/ACompleted

Evaluation of the PicoWay™ Laser System With 730nm and Resolve™ Fusion Handpieces for Treatment of Benign Pigmented Lesions and Wrinkles

Candela Corporation·interventional·Posted Dec 13, 2018·Updated Dec 1, 2023

In Brief

A clinical study evaluating PicoWay™ 532nm fractional handpiece, PicoWay™ 730nm wavelength, and 1 other intervention for Benign Pigmented Lesions and Facial Wrinkles. Completed, enrolled 115 participants across 1 site.

Detailed Summary

Evaluation of the PicoWay™ Laser System With 730nm and Resolve™ Fusion Handpieces for Treatment of Benign Pigmented Lesions and Wrinkles.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 13, 2018
Enrollment StartDec 5, 2018
Primary CompletionNov 12, 2020
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 7.6 years ago

Interventions

PicoWay™ 532nm fractional handpiecedevice

PicoWay™ Laser System is picosecond 532/1064/785 laser

PicoWay™ 730nm wavelengthdevice

PicoWay™ Laser System is picosecond 532/1064/785 laser

PicoWay™ 1064nm fractional handpiecedevice

PicoWay™ Laser System is picosecond 532/1064/785 laser